Kayne Anderson Rudnick Investment Management LLC decreased its holdings in shares of Exponent, Inc. (NASDAQ:EXPO - Free Report) by 0.8% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 4,736,557 shares of the business services provider's stock after selling 38,920 shares during the quarter. Kayne Anderson Rudnick Investment Management LLC owned approximately 9.33% of Exponent worth $422,027,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also recently bought and sold shares of EXPO. Barclays PLC grew its position in Exponent by 219.0% in the 3rd quarter. Barclays PLC now owns 96,526 shares of the business services provider's stock worth $11,127,000 after purchasing an additional 66,263 shares during the last quarter. Allspring Global Investments Holdings LLC increased its position in Exponent by 223.4% in the 4th quarter. Allspring Global Investments Holdings LLC now owns 6,158 shares of the business services provider's stock valued at $541,000 after acquiring an additional 4,254 shares during the period. KBC Group NV raised its stake in Exponent by 62.4% during the 4th quarter. KBC Group NV now owns 2,274 shares of the business services provider's stock valued at $203,000 after acquiring an additional 874 shares in the last quarter. PineStone Asset Management Inc. raised its stake in Exponent by 12.4% during the 4th quarter. PineStone Asset Management Inc. now owns 98,311 shares of the business services provider's stock valued at $8,760,000 after acquiring an additional 10,811 shares in the last quarter. Finally, Empowered Funds LLC raised its stake in Exponent by 28.8% during the 4th quarter. Empowered Funds LLC now owns 12,272 shares of the business services provider's stock valued at $1,093,000 after acquiring an additional 2,747 shares in the last quarter. Institutional investors and hedge funds own 92.37% of the company's stock.
Exponent Price Performance
Shares of EXPO traded down $1.67 during trading hours on Wednesday, reaching $75.87. 324,367 shares of the company's stock traded hands, compared to its average volume of 247,462. The firm has a market capitalization of $3.85 billion, a price-to-earnings ratio of 35.79 and a beta of 0.95. The business's fifty day simple moving average is $78.65 and its two-hundred day simple moving average is $86.72. Exponent, Inc. has a twelve month low of $73.37 and a twelve month high of $115.75.
Exponent (NASDAQ:EXPO - Get Free Report) last released its earnings results on Thursday, May 1st. The business services provider reported $0.52 EPS for the quarter, beating the consensus estimate of $0.48 by $0.04. Exponent had a net margin of 19.52% and a return on equity of 27.27%. The firm had revenue of $137.44 million for the quarter, compared to analysts' expectations of $134.63 million. During the same quarter last year, the company earned $0.59 EPS. Exponent's quarterly revenue was up .2% on a year-over-year basis. On average, equities research analysts expect that Exponent, Inc. will post 1.98 EPS for the current year.
Exponent Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Friday, June 20th. Investors of record on Friday, June 6th will be paid a dividend of $0.30 per share. The ex-dividend date is Friday, June 6th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 1.58%. Exponent's dividend payout ratio is presently 58.54%.
Insider Buying and Selling
In other news, VP John Pye sold 2,000 shares of Exponent stock in a transaction that occurred on Friday, May 23rd. The shares were sold at an average price of $76.32, for a total value of $152,640.00. Following the transaction, the vice president now owns 29,204 shares of the company's stock, valued at $2,228,849.28. The trade was a 6.41% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, VP Bradley A. James sold 2,694 shares of the business's stock in a transaction that occurred on Tuesday, May 20th. The stock was sold at an average price of $79.52, for a total transaction of $214,226.88. The disclosure for this sale can be found here. Insiders have sold a total of 6,267 shares of company stock valued at $489,120 over the last quarter. Corporate insiders own 2.10% of the company's stock.
Exponent Company Profile
(
Free Report)
Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.
Featured Articles

Before you consider Exponent, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exponent wasn't on the list.
While Exponent currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.